Makers Laboratories Limited (NSE:MAKERSL)
182.88
+1.62 (0.89%)
At close: Sep 23, 2026
Makers Laboratories Revenue
Makers Laboratories had revenue of 427.72M INR in the quarter ending June 30, 2026, with 22.20% growth. This brings the company's revenue in the last twelve months to 1.49B, up 17.82% year-over-year. In the fiscal year ending March 31, 2026, Makers Laboratories had annual revenue of 1.41B with 16.30% growth.
Revenue (ttm)
1.49B
Revenue Growth
+17.82%
P/S Ratio
0.73
Revenue / Employee
13.04M
Employees
114
Market Cap
1.09B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.41B | 197.47M | 16.30% |
| Mar 31, 2025 | 1.21B | 167.37M | 16.03% |
| Mar 31, 2024 | 1.04B | 31.12M | 3.07% |
| Mar 31, 2023 | 1.01B | -268.89M | -20.98% |
| Mar 31, 2022 | 1.28B | 595.25M | 86.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Godavari Drugs | 1.11B |
| Concord Drugs | 860.69M |
| Speciality Medicines | 752.85M |
| Mercury Laboratories | 737.65M |
| Asston Pharmaceuticals | 254.69M |